F Against Proforma Invoice Pembrolizumab Import Data from India (DGFT 2022–2026)

Q: Who are the top buyers of Pembrolizumab from India and how much does F Against Proforma Invoice import?

India exports Pembrolizumab to 66 buyers globally worth $677.5K. F Against Proforma Invoice imports $48.9K (2.5% market share) with 6 shipments from BRAZIL.

Q: What is the average order value for F Against Proforma Invoice's Pembrolizumab imports?

F Against Proforma Invoice's average Pembrolizumab order value is $8.1K per consignment, based on 6 shipments totaling $48.9K.

Q: Who supplies Pembrolizumab to F Against Proforma Invoice?

Top Indian Pembrolizumab suppliers: GNH INDIA PHARMACEUTICALS LIMITED ($285.3K), GEMINI HEALTHWORLD LLP ($212.6K), 3S PHARMACEUTICALS INDIA PRIVATE LIMITED ($201.7K), VAMA LIFECARE PRIVATE LIMITED ($181.3K), SHREE KRISHNA LIFECARE ($174.0K).

Q: Who are the top Pembrolizumab importers from India?

Top Pembrolizumab importers: INDIRA GANDHI MEMORIAL HOSPITAL ($130.1K), AS PER INVOICE ($105.6K), MERMISI LLC ($59.9K), KARLENE SMALL ($53.3K), F AGAINST PROFORMA INVOICE ($48.9K).

Suresh Sormare

Pembrolizumab

India Pharmaceutical Trade Intelligence

$1.9M34 Suppliers21 CountriesHS 30021500

ExportsIndia → BRAZIL44.6%India → ZIMBABWE8.5%

ImportsIRELAND → India$2.3B SINGAPORE → India$85.8M

#1 Supplier: GNH INDIA #1 Buyer: INDIRA GANDHI

F Against Proforma Invoice — Pembrolizumab Importer #5 | $48.9K Trade Value | TransData Nexus | TransData Nexus

F Against Proforma Invoice — Pembrolizumab Importer Profile

Pharmaceutical Importer · #5 buyer for Pembrolizumab · $48.9K import value · 6 shipments · BRAZIL · DGFT Verified

F Against Proforma Invoice is the #5 importer of Pembrolizumab from India with $48.9K in import value and 6 verified shipments. F Against Proforma Invoice holds a 2.5% market share in Pembrolizumab imports based in BRAZIL.

F Against Proforma Invoice — Pembrolizumab Import Profile: Suppliers, Formulations & Sources

F Against Proforma Invoice — Pembrolizumab import analysis from Indian Customs (DGFT) data.

Who Supplies Pembrolizumab to F Against Proforma Invoice?

Supplier	Value	Shipments	% Share
GNH INDIA PHARMACEUTICALS LIMITED	$285.3K	6	4
GEMINI HEALTHWORLD LLP	$212.6K	26	1
3S PHARMACEUTICALS INDIA PRIVATE LIMITED	$201.7K	12	2
VAMA LIFECARE PRIVATE LIMITED	$181.3K	19	1

How Does F Against Proforma Invoice Compare to Nearest Pembrolizumab Importers?

Buyers ranked immediately above and below #5 by import value

#	Buyer	Country	Import Value	Shipments	Avg/Shipment
3	MERMISI LLC	GEORGIA	$59.9K	6	$10.0K
4	KARLENE SMALL	JAMAICA	$53.3K	2	$26.7K
5	F AGAINST PROFORMA INVOICE ★	BRAZIL	$48.9K	6	$8.1K
6	KEISHA YOUNG-HENRY	JAMAICA	$47.8K	2	$23.9K
7	RICARDO LUIZ BARBOZA	BRAZIL	$47.4K	7	$6.8K

F Against Proforma Invoice ranks #5 among 66 Pembrolizumab importers from India. Average shipment value of $8.1K compared to the market average of $10.3K. The closest competitors by value are MERMISI LLC and KARLENE SMALL.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pembrolizumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
2.Buyer Identification: F Against Proforma Invoice matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
4.Market Share: Calculated as F Against Proforma Invoice's capped import value divided by total capped export value for Pembrolizumab across all Indian exporters.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 21+ countries, 66+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pembrolizumab

Pembrolizumab

F Against Proforma Invoice — Pembrolizumab Importer Profile

F Against Proforma Invoice — Pembrolizumab Import Profile: Suppliers, Formulations & Sources

Who Supplies Pembrolizumab to F Against Proforma Invoice?

How Does F Against Proforma Invoice Compare to Nearest Pembrolizumab Importers?

Regulatory Requirements: Importing Pembrolizumab into Brazil

Regulatory Authority

Approval Process for Generic Pembrolizumab

GMP Requirements

Import Licence & Documentation

Labeling & Packaging

Who Are the Top Buyers of Pembrolizumab from India and How Much Does F Against Proforma Invoice Import?

What Is the Average Order Value for F Against Proforma Invoice's Pembrolizumab Imports?

Who Supplies Pembrolizumab to F Against Proforma Invoice?

How Does F Against Proforma Invoice Compare to Other Pembrolizumab Importers?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pembrolizumab Import Data for F Against Proforma Invoice

F Against Proforma Invoice × Pembrolizumab

Related Analysis

Need Detailed Import Data?

Data Source